Orca Bio

Associate Director, Marketing

Remote

Orca Bio Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, HealthcareIndustries

Requirements

Candidates should possess a Bachelor’s degree in Life Sciences, Marketing, Finance, or a related field, with an MBA or other advanced degree being preferred. They should have at least 8 years of experience in the biopharmaceutical industry, demonstrating a strong understanding of marketing strategy and tactical execution. Clinical proficiency in acute leukemia and bone marrow transplantation, coupled with a track record of collaborating with clinical and scientific experts, is also required. Proficiency with Veeva PromoMats is a desired qualification.

Responsibilities

The Associate Director, Marketing will lead the promotional launch of Orca-T, driving robust pre-launch, launch, and post-launch strategies and omnichannel tactics to maximize market penetration and product adoption. They will be responsible for developing unique and effective HCP engagement strategies, collaborating with the Market Development team and other Commercial personnel to shape a comprehensive HCP Marketing tactical plan, and managing agency partners to deliver consistent results. This role involves leading the execution of a full HCP-facing tactical suite, contributing to omnichannel strategy, and managing the promotions tactical budget. Furthermore, the Associate Director will contribute to advisory board content, KOL engagement, and effectively manage the Sales team to optimize messaging and assets, all while thriving in a dynamic and entrepreneurial environment.

Skills

HCP engagement strategies
Brand messaging development
Omnichannel media strategy
Promotional tactics
Market launch planning
Cross-functional collaboration

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Key Metrics

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI